HighTower Advisors LLC Sells 19,840 Shares of HealthEquity, Inc. (NASDAQ:HQY)

HighTower Advisors LLC cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 90,705 shares of the company’s stock after selling 19,840 shares during the quarter. HighTower Advisors LLC’s holdings in HealthEquity were worth $7,422,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. CWM LLC lifted its position in HealthEquity by 6.9% in the 2nd quarter. CWM LLC now owns 3,958 shares of the company’s stock worth $341,000 after buying an additional 255 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of HealthEquity by 48.5% in the 2nd quarter. SG Americas Securities LLC now owns 3,798 shares of the company’s stock worth $327,000 after acquiring an additional 1,241 shares during the last quarter. Sequoia Financial Advisors LLC bought a new stake in shares of HealthEquity in the 2nd quarter worth approximately $1,122,000. Wealth Enhancement Advisory Services LLC bought a new stake in shares of HealthEquity in the 2nd quarter worth approximately $265,000. Finally, Narus Financial Partners LLC lifted its holdings in shares of HealthEquity by 47.8% in the 2nd quarter. Narus Financial Partners LLC now owns 6,526 shares of the company’s stock worth $563,000 after acquiring an additional 2,110 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Price Performance

HealthEquity stock opened at $101.00 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The company has a market capitalization of $8.82 billion, a price-to-earnings ratio of 84.17, a price-to-earnings-growth ratio of 1.57 and a beta of 0.55. The company’s 50 day simple moving average is $92.81 and its 200-day simple moving average is $83.79. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of recent research reports. Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. JMP Securities reiterated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $109.64.

Insider Activity

In related news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the sale, the director now owns 3,784 shares in the company, valued at $363,642.40. This represents a 21.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is currently owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.